Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Japan Pockets $5.3M in Stock Placement

NEW YORK (GenomeWeb News) — Third Wave Japan, a subsidiary of Third Wave Technologies, has raised roughly $5.3 million in a stock placement, the company stated in a filing with the Securities and Exchange Commission yesterday.
 
Third Wave Japan sold 7,112 shares of common stock at ¥90,000 ($743) per share to Mitsubishi, Shimadzu, CSK Institute for Sustainability, Daiichi Pure Chemicals, BML, and Toppan Printing.
 
Third Wave Japan said the investors purchased roughly 12.9 percent of its outstanding shares and around 12.4 percent of the company’s outstanding equity.
 
Including previous investments, Mitsubishi and CSK now own around 27 percent of Third Wave Japan, or 31 percent after exercise of warrants.
 
The company said the convertible Series A preferred stock has an 8-percent, non-cumulative dividend.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.